BSE - Delayed Quote INR
Gujarat Themis Biosyn Limited (GUJTHEM.BO)
312.05
-13.85
(-4.25%)
At close: 3:44:59 PM GMT+5:30
Key Executives
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Tapas Bhudebendranath Guhathakurata | Chief Executive Officer | -- | -- | -- |
Mr. Bhavik Shah | Chief Financial Officer | -- | -- | -- |
Mr. Do-Seon Kim | Chief Technical Officer | -- | -- | -- |
Mr. Vineet G. Gawankar | Company Secretary & Compliance Officer | -- | -- | -- |
Mr. Rajneesh Kedarnath Anand | Senior Executive | -- | -- | 1954 |
Gujarat Themis Biosyn Limited
Themis House
11/12 Udyog Nagar S.V Road Goregaon (West)
Mumbai, 400104
India
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 159
Description
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis; Rifamycin-O; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
Corporate Governance
Gujarat Themis Biosyn Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
July 24, 2025 at 10:59 AM UTC - July 28, 2025 at 12:00 PM UTC
Gujarat Themis Biosyn Limited Earnings Date
Recent Events
July 15, 2024 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
INDSWFTLTD.NS Ind-Swift Limited
14.58
-2.34%
MANKIND.BO Mankind Pharma Limited
2,533.05
-0.69%
CAPLIPOINT.NS Caplin Point Laboratories Limited
2,252.40
+5.90%
NEULANDLAB.NS Neuland Laboratories Limited
11,194.00
+0.39%
IOLCP.NS IOL Chemicals and Pharmaceuticals Limited
86.27
+9.00%
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,224.70
+0.04%
DIVISLAB.NS Divi's Laboratories Limited
6,552.00
+1.54%